Paper8325342
Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.
Martinon F and 7 others. Eur J Immunol, 1993. Cited by 361 papers, by iCite.
Cite this record
ConductScience Library. Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Papers, record 8325342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8325342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Viral | Major topic |
| Influenza A virus | Major topic |
| Nucleoproteins | Major topic |
| RNA, Messenger | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Viral Core Proteins | Major topic |
| Animals | |
| Cytotoxicity, Immunologic | |
| Immunity, Cellular | |
| Liposomes | |
| Mice | |
| Mice, Inbred Strains | |
| Nucleocapsid Proteins | |
| Vaccines, Synthetic | |
| Viral Vaccines |
Source PubMed
Cited by228
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 361 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42853631 | mRNA-based therapies: From molecular discovery to clinical revolution. | Genet Mol Biol | 2026 | https://conductscience.org/library/papers/42853631 | PubMed |
| 42782773 | mRNA Vaccines as Novel Immunotherapeutic Approaches in Gastrointestinal Cancers. | Cells | 2026 | https://conductscience.org/library/papers/42782773 | PubMed |
| 42746222 | Target, silence, replace: a review on RNA-based drugs in modern medicine. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42746222 | PubMed |
| 42728430 | Structural evolution of ionizable lipids for nucleic acid delivery. | Nat Rev Chem | 2026 | https://conductscience.org/library/papers/42728430 | PubMed |
| 42651807 | Engineering the Future of Precision Medicine: A Comprehensive Guide to RNA Therapeutics. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42651807 | PubMed |
| 42514871 | Analytical Characterization and Stability Assessment of RNA-Based Vaccines. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514871 | PubMed |
| 42380588 | Advancements in RNA-based therapies from bench to bedside. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42380588 | PubMed |
| 42257193 | Synthetic Polymers for Drug, Gene, and Vaccine Delivery. | Polym Sci Technol | 2025 | https://conductscience.org/library/papers/42257193 | PubMed |
| 42086626 | Optimizing mouse models for mRNA vaccines: addressing dose translation challenges. | Sci Rep | 2026 | https://conductscience.org/library/papers/42086626 | PubMed |
| 41986715 | mRNA vaccines engage unconventional pathways in CD8+ T cell priming. | Nature | 2026 | https://conductscience.org/library/papers/41986715 | PubMed |
| 41962202 | Recent advances in LNP-mRNA vaccines. | Colloids Surf B Biointerfaces | 2026 | https://conductscience.org/library/papers/41962202 | PubMed |
| 41766818 | mRNA vaccines transform personalized lung cancer treatment. | Front Immunol | 2025 | https://conductscience.org/library/papers/41766818 | PubMed |
| 41586257 | Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications. | Exp Biol Med (Maywood) | 2025 | https://conductscience.org/library/papers/41586257 | PubMed |
| 41535643 | The mRNA-Based Innovative Strategy: Progress and Challenges. | Nanomicro Lett | 2026 | https://conductscience.org/library/papers/41535643 | PubMed |
| 41479562 | mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes. | Acta Naturae | 2025 | https://conductscience.org/library/papers/41479562 | PubMed |
| 41295541 | Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295541 | PubMed |
| 41150434 | Health Technology Assessment of mRNA Vaccines: Clinical, Economic, and Public Health Implications. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41150434 | PubMed |
| 40952557 | mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives. | Curr Med Sci | 2025 | https://conductscience.org/library/papers/40952557 | PubMed |
| 40905915 | Using modified mRNA for cardiomyocyte proliferation and cardiac genetic disease modelling and treatment. | Biochem Soc Trans | 2025 | https://conductscience.org/library/papers/40905915 | PubMed |
| 40881859 | Unraveling the potential: mRNA therapeutics in oncology. | Front Oncol | 2025 | https://conductscience.org/library/papers/40881859 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8325342
GET https://conductscience.org/api/papers/v1/8325342/cited_by?page=2